EN
HI
Syncom Formulations (India) Chart
Syncom Formulations (India) Share Key Metrics
Volume
17.84 L
Market Cap
1107.32 CR
LTQ@LTP
200@11.78
ATP
11.83
Var Margin
20.1 %
Circuit Range
9.36-14.04
Delivery %
59.04 %
Value
2.11 CR
ASM/GSM
No
Market Lot
1
Summary
At 20 Mar, 2026 | 15:31, Syncom Formulations (India) share price stands at ₹11.78, showing a 0.08% 0.68 for the day. The stock’s intraday movement has stayed between ₹11.64 and ₹11.99, while on a 52-week basis it has fluctuated from ₹11.47 to ₹23.49.
In terms of trading activity, Syncom Formulations (India) has recorded a volume of 1783634 shares, with a market capitalisation of ₹940000000. The stock’s Average Traded Price (ATP) stands at ₹1183, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 200,1178. The stock operates within a circuit range of ₹9.36-14.04, with a Value of ₹2.11 CR. The Delivery Percentage for the day is 59.04%. Additionally, Syncom Formulations (India) currently falls under the No framework, and trades with a market lot size of 1.
Syncom Formulations (India) Fundamentals
View MoreP/E Ratio
16.29
P/B Ratio
2.83
Div. Yield
0
Sector P/E
60.47
Sector P/B
2.66
Sec. Div. Yield
0.59
Syncom Formulations (India) Resistance and Support
Pivot 11.77
Resistance
First Resistance
11.88
Second Resistance
12.07
Third Resistance
12.18
Support
First Support
11.58
Second Support
11.47
Third Support
11.28
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
Syncom Formulations (India) News
About Syncom Formulations (India)
NSE : 11992
BSE : 524470
ISIN : INE312C01025
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Mr. Ankit Kedarmal Bankda | Executive Chairman & Whole-time Director |
| Mr. Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
Lincoln Pharmaceuticals Ltd.
600.95
5.10 (0.86%)
Venus Remedies Ltd.
868.25
12.85 (1.50%)
Hester Biosciences Ltd.
1395.00
-27.90 (1.96%)
Bajaj Healthcare Ltd.
312.95
10.70 (3.54%)
Beta Drugs Ltd.
1106.10
36.40 (3.40%)
GPT Healthcare Ltd.
120.65
-3.18 (2.57%)
Laxmi Dental Ltd.
173.71
-3.48 (1.96%)
Anuh Pharma Ltd.
74.31
0.02 (0.03%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 11.78 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 16.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 2.83. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 60.47 & 2.66 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 1107.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 23.49 & 11.47. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
